共同应对全球卫生优先事项：协调行动和共同责任的系统方法2025（英）-艾昆纬

White PaperComing Together to Address Global Health Priorities: A Systematic Approach for Concerted Action and Shared ResponsibilityWhite paper commissioned by SanofiTable of contentsAcronyms 2Introduction 1Section I. Current challenges and trends in global health 2Salient global health challenges 2Addressing global health challenges across underserved and vulnerable populations globally: A perspective on equity in access to care and health outcomes 7The role of integrated care 8Bringing it all together 9Section II. Tackling global health challenges: A systematic approach 10Objective and overview of the Global Health Needs Tool 10Identifying and addressing global health needs 13Section III. Shaping solutions 14Shared responsibility in shaping more accessible, equitable, scalable and sustainable healthcare solutions 14Guiding future action: Broadening sustainable and equitable access to healthcare and establishing more impactful public-private partnerships 15Key elements of access guiding collaborative action: A view from Sanofi 16Conclusions 18References 19About the authors 24Acknowledgements 24Annex A. Global Health Needs Tool: Methodological considerations 25Annex B. Identifying and addressing global health needs 27 iqvia.com | 2AcronymsAMRAntimicrobial resistanceCDCommunicable diseaseCOPDChronic obstructive pulmonary diseaseDAHDevelopment assistance for healthDALYDisability-adjusted life yearEMEAEurope, Middle East and AfricaGHNTGlobal Health Needs ToolGHUSanofi’s Global Health UnitHCPHealthcare professionalHICHigh-income countryHIVHuman immunodeficiency virusIHMEInstitute for Health Metrics and EvaluationLICLow-income countryLMICLow- and middle-income countryNCDNon-communicable diseaseOOPOut-of-pocket expendituresRWEReal-world evidenceSDGSustainable Development GoalsUHCUniversal health coverageUMICUpper middle-income countryWHOWorld Health Organization1 | Coming Together to Address Global Health Priorities: A Systematic Approach for Concerted Action and Shared ResponsibilityIntroductionAchieving equitable, inclusive, and sustainable access to high-quality healthcare is a central aspiration for a wide variety of national and international stakeholders, including many non-governmental actors, and is a key pillar of the Sustainable Development Goals (SDGs). The pharmaceutical and medical technologies industries have been under pressure to play their part by contributing to long-term solutions and have made commitments accordingly, although major gaps remain. These players are emphasizing that insufficient awareness, lack of access to diagnostic tools, inadequate healthcare capacity and capabilities, sub-optimal ‘last mile’ distribution, and other social and political determinants can significantly affect access to care, proving that barriers to achieving a scalable and sustainable impact are broader than price alone.Keeping these issues in mind, this paper discusses the importance of using evidence-based analysis to ultimately address healt